2024-516016-17-00CompletedPhase 1
A clinical study of MK-3214 in healthy people (MK-3214-001)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 10 Apr 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 4 Sept 2024
- Start date
- Oct 2024
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2024-516016-17-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 32
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.